Articles published in Journal of Vaccines & Vaccination have been cited by esteemed scholars and scientists all around the world. Journal of Vaccines & Vaccination has got h-index 24, which means every article in Journal of Vaccines & Vaccination has got 24 average citations.

Following are the list of articles that have cited the articles published in Journal of Vaccines & Vaccination.

  2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010

Total published articles

67 60 59 65 71 11 19 26 45 44 52 59 54 13 14

Research, Review articles and Editorials

14 14 19 41 29 11 15 16 17 34 40 42 38 10 10

Research communications, Review communications, Editorial communications, Case reports and Commentary

38 46 40 30 42 0 4 10 28 10 12 17 21 3 4

Conference proceedings

18 8 32 23 0 0 112 104 154 315 180 116 110 122 0

Citations received as per Google Scholar, other indexing platforms and portals

121 206 193 258 232 212 200 205 224 245 110 61 22 20 0
Journal total citations count 2341
Journal impact factor 2.87
Journal 5 years impact factor 3.73
Journal cite score 4.69
Journal h-index 24
Important citations

B Cell Epitope-Based Vaccination Therapy

B-cell populations are expanded in breast cancer patients compared with healthy controls.

Syntheses and Functional Studies of Self-Adjuvanting Anti-HER2 Cancer Vaccines.

Immunological Evaluation of Co-Assembling a Lipidated Peptide Antigen and Lipophilic Adjuvants: Self-Adjuvanting Anti-Breast-Cancer Vaccine Candidates.

RESEARCH AND REVIEWS: JOURNAL OF MICROBIOLOGY AND BIOTECHNOLOGY Novel Aspects and Strategies in Vaccination

Novel Aspects and Strategies in Vaccination

MVA85A vaccine to enhance BCG for preventing tuberculosis

Mechanistic approach of drug discovery from natural substances for thrombocytopenia: A major cause of death in dengue fever patients

RESEARCH AND REVIEWS: JOURNAL OF MICROBIOLOGY AND BIOTECHNOLOGY Novel Aspects and Strategies in Vaccination

Novel Aspects and Strategies in Vaccination

A Mini Review: Ethical Usage of Animals in Pharmacological Research

TETRAVALENT DENGUE VACCINE: CHILDREN/ADOLESCENTS IN BRAZIL Immunogenicity and Safety of a Recombinant Tetravalent Dengue Vaccine in Children and Adolescents Ages 9-16 Years in Brazil

Seguridad e inmunogenicidad en ensayos clínicos de vacunas para Dengue

An insight into dengue virus proteins as potential drug/vaccine targets

Dengue Fever: Symptoms, Treatments and Prevention; A General Perspective

Immunogenicity of the CYD tetravalent dengue vaccine using an accelerated schedule: Randomised phase II study in US adults

Anti-dengue Vaccines: From Development to Clinical Trials.

Zika Virus (ZIKV) Infection: A Review

Ancient Diseases-Microbial Impact

Efficacy of tetravalent dengue vaccine in Thai schoolchildren – Authors' reply